214 related articles for article (PubMed ID: 33530281)
21. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients.
Wan T; Shao J; Hu B; Liu G; Luo P; Zhou Y
Onco Targets Ther; 2018; 11():383-393. PubMed ID: 29398920
[TBL] [Abstract][Full Text] [Related]
23. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
[TBL] [Abstract][Full Text] [Related]
24. Anoctamin Channels in Human Myometrium: A Novel Target for Tocolysis.
Danielsson J; Vink J; Hyuga S; Fu XW; Funayama H; Wapner R; Blanks AM; Gallos G
Reprod Sci; 2018 Nov; 25(11):1589-1600. PubMed ID: 29471754
[TBL] [Abstract][Full Text] [Related]
25. Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers.
Kim T; Cho S; Oh H; Hur J; Kim H; Choi YH; Jeon S; Yang YD; Kim SH
Molecules; 2020 Nov; 25(21):. PubMed ID: 33172169
[TBL] [Abstract][Full Text] [Related]
26. [Effects of stable ANO1 overexpression on biological behaviors of human laryngeal squamous cell carcinoma Hep-2 cells in vitro].
Li Y; Zhang J; Yang K; Zhang F; Chen R; Chen D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):251-5. PubMed ID: 24589607
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
28. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
Ayoub C; Wasylyk C; Li Y; Thomas E; Marisa L; Robé A; Roux M; Abecassis J; de Reyniès A; Wasylyk B
Br J Cancer; 2010 Aug; 103(5):715-26. PubMed ID: 20664600
[TBL] [Abstract][Full Text] [Related]
29. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
30. The role of anoctamin 1 in liver disease.
Li X; Wang Y; Zhang L; Yao S; Liu Q; Jin H; Tuo B
J Cell Mol Med; 2024 May; 28(9):e18320. PubMed ID: 38685684
[TBL] [Abstract][Full Text] [Related]
31. Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.
Sim KM; Lee YS; Kim HJ; Cho CH; Yi GS; Park MJ; Hwang EM; Park JY
Cells; 2020 Apr; 9(5):. PubMed ID: 32357567
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
Hu L; Huang M; Yuan Q; Kong F
Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
[TBL] [Abstract][Full Text] [Related]
33. ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis.
Deng CM; Zhang GG; Liu QW; Xu JJ; Liu ZC; Yang J; Xu TY; Li ZG; Zhang F; Li B
Cancer Res; 2023 Jun; 83(11):1851-1865. PubMed ID: 36912612
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ANO1 by
Jeon D; Jo M; Lee Y; Park SH; Phan HTL; Nam JH; Namkung W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674697
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma.
Finegersh A; Kulich S; Guo T; Favorov AV; Fertig EJ; Danilova LV; Gaykalova DA; Califano JA; Duvvuri U
Sci Rep; 2017 Nov; 7(1):15173. PubMed ID: 29123240
[TBL] [Abstract][Full Text] [Related]
36. Diversity-oriented generation and biological evaluation of new chemical scaffolds bearing a 2,2-dimethyl-2H-chromene unit: Discovery of novel potent ANO1 inhibitors.
Seo Y; Choi J; Lee JH; Kim TG; Park SH; Han G; Namkung W; Kim I
Bioorg Chem; 2020 Aug; 101():104000. PubMed ID: 32592976
[TBL] [Abstract][Full Text] [Related]
37. miR-106a Targets Anoctamin 1 (ANO1) to Regulate Lipopolysaccharide (LPS)-Induced Inflammatory Response in Macrophages.
Heng J; Wu D; Lu S; Zhao Y
Med Sci Monit; 2020 Oct; 26():e922479. PubMed ID: 33037174
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors.
Seo Y; Kim J; Chang J; Kim SS; Namkung W; Kim I
Eur J Med Chem; 2018 Dec; 160():245-255. PubMed ID: 30347323
[TBL] [Abstract][Full Text] [Related]
39. MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma.
Liu W; He JZ; Wang SH; Liu DK; Bai XF; Xu XE; Wu JY; Jiang Y; Li CQ; Chen LQ; Li EM; Xu LY
Br J Cancer; 2018 May; 118(11):1476-1484. PubMed ID: 29765149
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
